These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27679424)

  • 21. Review: the Kell, Duffy, and Kidd blood group systems.
    Westhoff CM; Reid ME
    Immunohematology; 2004; 20(1):37-49. PubMed ID: 15373667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hemolytic disease of the newborn due to anti-Ku (author's transl)].
    Huang HJ; Tagawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):119-21. PubMed ID: 7199551
    [No Abstract]   [Full Text] [Related]  

  • 23. Neonatal anti-Kell isoimmune hemolytic disease with spherocytes.
    Merlob P; Reisner SH; Zaizov R
    Pediatr Hematol Oncol; 1986; 3(2):175-8. PubMed ID: 3153228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Causes of fetal anemia in hemolytic disease due to anti-K.
    Daniels G; Hadley A; Green CA
    Transfusion; 2003 Jan; 43(1):115-6. PubMed ID: 12519439
    [No Abstract]   [Full Text] [Related]  

  • 25. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.
    Poole J; Warke N; Hustinx H; Taleghani BM; Martin P; Finning K; Crew VK; Green C; Bromilow I; Daniels G
    Transfusion; 2006 Nov; 46(11):1879-85. PubMed ID: 17076841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kell hemolytic disease of the newborn: A case for expanded prenatal antibody screening.
    Spivey MA; Wilson JT; Taylor HL
    J Ark Med Soc; 1978 Jul; 75(2):73-5. PubMed ID: 149785
    [No Abstract]   [Full Text] [Related]  

  • 27. [Status of Kell incompatibility in a 15-year retrospective study of mother-child serology in clinical records].
    Schönitzer D
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():3-9. PubMed ID: 3596796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin.
    Dhodapkar KM; Blei F
    J Pediatr Hematol Oncol; 2001 Jan; 23(1):69-70. PubMed ID: 11196277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Isoimmunization to Kell factor, during pregnancy].
    Krug A; Bianchi R; Cornejo A; Farias S; Fuentes L
    Rev Chil Obstet Ginecol; 1988; 53(4):198-200. PubMed ID: 3155245
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre.
    Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N
    Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fetal death and benign hemolytic disease of the newborn from anti-Cellano alloimmunization: 2 new case reports].
    Rigal D; Juron-Dupraz F; Biggio B; Jouvenceaux A
    Rev Fr Transfus Immunohematol; 1982 Feb; 25(1):101-4. PubMed ID: 7071459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alloimmunisation via previous transfusion places female Kpb-negative recipients at risk for having children with clinically significant hemolytic disease of the newborn.
    Gorlin JB; Kelly L
    Vox Sang; 1994; 66(1):46-8. PubMed ID: 8146981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irregular antibodies causing hemolytic disease of the newborn.
    Weinstein L
    Obstet Gynecol Surv; 1976 Aug; 31(8):581-91. PubMed ID: 785325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exchange transfusions and top-up transfusions in neonates with Kell haemolytic disease compared to Rh D haemolytic disease.
    Rath ME; Smits-Wintjens VE; Lindenburg IT; Brand A; van Kamp IL; Oepkes D; Walther FJ; Lopriore E
    Vox Sang; 2011 Apr; 100(3):312-6. PubMed ID: 20849463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe haemolytic disease of the newborn due to anti-Js(b).
    Stanworth S; Fleetwood P; de Silva M
    Vox Sang; 2001; 81(2):134-5. PubMed ID: 11555475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current clinical management of anti-Kell alloimmunization in pregnancy.
    Santiago JC; Ramos-Corpas D; Oyonarte S; Montoya F
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe erythroblastosis fetalis secondary to anti-Kpb sensitization.
    Dacus JV; Spinnato JA
    Am J Obstet Gynecol; 1984 Dec; 150(7):888-9. PubMed ID: 6507516
    [No Abstract]   [Full Text] [Related]  

  • 38. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chorionic biopsy in management of severe Kell alloimmunization.
    Rodesch F; Lambermont M; Donner C; Simon P; Romasco F; Schwers J; Wybran J
    Am J Obstet Gynecol; 1987 Jan; 156(1):124-5. PubMed ID: 3799745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-K12 in the serum of two brothers: inheritance of the K:-12 phenotype.
    Beattie KM; Heinz B; Korol S; Oyen R; Marsh WL
    Rev Fr Transfus Immunohematol; 1982 Dec; 25(6):611-8. PubMed ID: 7170567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.